Previous studies showed that metformin improved liver fat and serum ALT levels in patients with NAFLD [13, 14], suggesting its potential beneficial effects in the treatment of NAFLD [15]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.